CD8A and neoplasm: ALT-803 increased the expression of GzB and perforin in NK cells and CD8+ T cells in a dose-dependent manner, suggesting that ALT-803 kills tumor cells by enhancing GzB and perforin expression and the subsequent activation of NK and CD8+ T cells (21).